Skip to main content
Premium Trial:

Request an Annual Quote

Sciex, Waters Partner to Provide Interoperable LC-MS Systems

NEW YORK – Sciex and Waters said on Tuesday that they are partnering to offer customers Sciex mass spectrometry systems fully configured and interoperable with Waters liquid chromatography instruments.

The collaboration will make it easier for Sciex mass spec customers to configure their systems with Waters' UPLC instruments, which can provide increased mass spec sensitivity for the detection and quantification of low abundance analytes.

The two companies have developed instrument control drivers that allow Sciex's OS software to directly control Waters Acquity UPLC I-Class Plus Systems, as well as the H-Class Plus, H-Class Plus Bio, and M-Class instruments.

"We strive to provide the best products and services, and live by the mantra, 'when customers talk, we listen,'" Dom Gostick, VP and general manager of LC-MS and chief technology officer at Sciex, said in a statement. "Through this collaboration, we are broadening the variety of LC instruments available to our growing customer base."

"Scientists will immediately benefit from ease of access to industry-leading UPLC systems," said Jon Pratt, senior VP at Waters. "This agreement provides for a smooth, integrated experience for customers with the coordinated support of Waters’ expertise and service."

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.